Massachusetts Institute of Technology (MIT)

Integrated Continuous Manufacturing in Pharmaceuticals

An innovative manufacturing platform called integrated continuous manufacturing (ICM) represents a completely modernized model for drug manufacturing. In contrast to batch processes, ICM’s unique operational advantages will allow for cost-competitive end-to-end manufacturing and enable a more robust and responsive supply chain for critical drugs.

Continuous Pharmaceutical Manufacturing

Umicore Licenses Cross-Coupling Catalysts from MIT

Digitization’s Impact on the Pharmaceutical Industry

Roche Agrees Cancer Partnership with SQZ Biotech

Materials Know-How

Battery Material Producers Remain Optimistic

BASF Shifts R&D Focus

Big Drugmakers Think Small with Nanomedicine Deals

GSK Plans $1 Million Prize to Jump-start "Electroceuticals"

Obama Eyes Investments In Technology Manufacturing

Chemist, Biologist Wins MIT Inventor's Prize

South Africa Taps Patent Pool for Neglected Disease